CA2189567A1 - Composes bicycliques substitues, condenses et pontes, utilises comme agents therapeutiques - Google Patents

Composes bicycliques substitues, condenses et pontes, utilises comme agents therapeutiques

Info

Publication number
CA2189567A1
CA2189567A1 CA002189567A CA2189567A CA2189567A1 CA 2189567 A1 CA2189567 A1 CA 2189567A1 CA 002189567 A CA002189567 A CA 002189567A CA 2189567 A CA2189567 A CA 2189567A CA 2189567 A1 CA2189567 A1 CA 2189567A1
Authority
CA
Canada
Prior art keywords
therapeutic agents
bridged bicyclic
substituted fused
bicyclic compounds
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002189567A
Other languages
English (en)
Other versions
CA2189567C (fr
Inventor
Hong Hu
Gunnar Erik Jagdmann, Jr.
Jose Serafin Mendoza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/392,710 external-priority patent/US5583221A/en
Application filed by Individual filed Critical Individual
Publication of CA2189567A1 publication Critical patent/CA2189567A1/fr
Application granted granted Critical
Publication of CA2189567C publication Critical patent/CA2189567C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002189567A 1994-05-04 1995-03-15 Composes bicycliques substitues, condenses et pontes, utilises comme agents therapeutiques Expired - Fee Related CA2189567C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23764594A 1994-05-04 1994-05-04
US08/237,645 1994-05-04
US08/392,710 1995-02-23
US08/392,710 US5583221A (en) 1994-05-04 1995-02-23 Substituted fused and bridged bicyclic compounds as therapeutic agents
PCT/US1995/003220 WO1995030640A1 (fr) 1994-05-04 1995-03-15 Composes bicycliques substitues, condenses et pontes, utilises comme agents therapeutiques

Publications (2)

Publication Number Publication Date
CA2189567A1 true CA2189567A1 (fr) 1995-11-16
CA2189567C CA2189567C (fr) 2006-02-14

Family

ID=35892272

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002189567A Expired - Fee Related CA2189567C (fr) 1994-05-04 1995-03-15 Composes bicycliques substitues, condenses et pontes, utilises comme agents therapeutiques

Country Status (1)

Country Link
CA (1) CA2189567C (fr)

Also Published As

Publication number Publication date
CA2189567C (fr) 2006-02-14

Similar Documents

Publication Publication Date Title
CA2137203A1 (fr) Inhibiteurs de la proteine kinase c
CA2272705A1 (fr) Derives de pyrimidines bicycliques fusionnes
CA2274464A1 (fr) Cetobenzamides s'utilisant comme inhibiteurs de la calpaine
CA2216535A1 (fr) Inhibiteurs de proteine kinase c
CA2237221A1 (fr) Inhibiteur de la proteine kinase c
IL125735A (en) Pharmaceutical compositions for the treatment of glaucoma comprising an inhibitor of serine-threonine kinase, tyrosine kinase or protein tyrosine phosphatase or an actin-disrupting compound
HU9302330D0 (en) 7-(substituted)-9-|(substituted glycyl)-amino¨-6-desmethyl-6-desoxy-tetracyclines, pharmaceutical preparatives containing them and methods for producing them
HU9302329D0 (en) 7-(substituted)-9-|(substituted glycyl)-amino¨-6-desmethyl-6-desoxy-tetracyclines, pharmaceutical preparatives containing them and methods for producing them
IL123002A0 (en) 1-Phenyl-2- phenylacetoxy- ethanone derivatives
CA2296665A1 (fr) Derives de la triazolo[4,5-d]pyrimidine en tant qu'agents antithrombotiques
AU3504393A (en) N-sulphonyl-2-oxoindole derivatives having affinity for vasopressin and/or ocytocin receptors
NO995006L (no) Nye forbindelser
NO973479L (no) Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme
CA2244785A1 (fr) Pentafluorobenzenesulfonamides et analogues
CA2163361A1 (fr) Derives de substitution de guanidines, agents therapeutiques
CA2252701A1 (fr) Inhibiteurs de proteine kinase c halo-substitues
CA2237189A1 (fr) 3-azetidinylalkylpiperidines ou -pyrrolidines en tant qu'antagonistes des tachykinines
CA2173876A1 (fr) Carbamates d'alcoxyalkyle obtenus a partir d'imidazol(1,2-a)pyridines
PL311266A1 (en) Application of indole derivatives as 5ht1 antagonists
CA2219359A1 (fr) Derives hydantoine utilises comme produits intermediaires pour principes actifs pharmaceutiques
CA2264005A1 (fr) Derives piperazino a fonction antagoniste de la neurokinine
CA2218887A1 (fr) Derives piperazino en tant qu'antagonistes des neurokinines
AU1998995A (en) Substituted fused and bridged bicyclic compounds as therapeutic agents
TW252979B (fr)
CA2281702A1 (fr) Derives de (4-piperidinyl)-1h-2-benzopyrane convenant comme antipsychotiques

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed